CXCR4 and neoplasm: Loss of DNA methylation in the promoter region of CXCR4 correlated with a more aggressive disease in terms of tumor stage, tumor size, SBR grade, 5demonstrated that concurrent epigenetic changes of CXCR4 and its ligand, CXCL12, correlated with shorter disease-free and overall survivals.